Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 1
1996 2
1997 1
1999 1
2004 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Thymoma: current medical and surgical management.
Kesler KA, Wright CD, Loehrer PJ Sr. Kesler KA, et al. Semin Neurol. 2004 Mar;24(1):63-73. doi: 10.1055/s-2004-829588. Semin Neurol. 2004. PMID: 15229793 Review.
Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial.
Loehrer PJ Sr, Elson P, Dreicer R, Hahn R, Nichols CR, Williams R, Einhorn LH. Loehrer PJ Sr, et al. J Clin Oncol. 1994 Mar;12(3):483-8. doi: 10.1200/JCO.1994.12.3.483. J Clin Oncol. 1994. PMID: 7509853 Clinical Trial.
For other patients, M-VACII dosages were methotrexate 40 mg/m2 (days 1, 15, and 22), vinblastine 4 mg/m2 (days 2, 15, and 22), doxorubicin 40 mg/m2 (day 2), and cisplatin 100 mg/m2 (day 2). In addition, rhG-CSF was administered at a dosage of 300 micrograms s …
For other patients, M-VACII dosages were methotrexate 40 mg/m2 (days 1, 15, and 22), vinblastine 4 mg/m2 (days 2, 15, and 22), doxoru …
Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.
Loehrer PJ Sr, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, Johnson D. Loehrer PJ Sr, et al. J Clin Oncol. 1997 Sep;15(9):3093-9. doi: 10.1200/JCO.1997.15.9.3093. J Clin Oncol. 1997. PMID: 9294472 Clinical Trial.
The median time to treatment failure was 93.2 months (range, 3 to 99.2+ months), and the median survival time was 93 months (range, 1 to 110 months). ...
The median time to treatment failure was 93.2 months (range, 3 to 99.2+ months), and the median survival time was 93 months (r …
A phase II study of weekly oral methotrexate and zidovudine (AZT) in advanced adenocarcinoma of the pancreas and hepatocellular carcinoma.
Miller KD, Loehrer PJ, Gonin R, Weber G, Ansari R, Pletcher W, McClean J, Spiridonidis CH, Mortimer J. Miller KD, et al. Invest New Drugs. 1996;14(2):207-12. doi: 10.1007/BF00210792. Invest New Drugs. 1996. PMID: 8913842 Clinical Trial.
One patient achieved a radiographic complete remission and 2 had stable disease. Two-thirds of patients progressed within 2 months of beginning therapy. ...
One patient achieved a radiographic complete remission and 2 had stable disease. Two-thirds of patients progressed within 2 mo …